Worldwide, 270 000 persons every year are diagnosed with renal (kidney) cancer. In 1/3 of these patients the cancer has already spread and the prognosis is unfortunately very poor. Oncorena develops a product based on orellanine, with the goal of a long-t
Worldwide, 270 000 persons every year are diagnosed with renal (kidney) cancer. In 1/3 of these patients the cancer has already spread and the prognosis is unfortunately very poor. Oncorena develops a product based on orellanine, with the goal of a long-t